Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
Type 2 diabetes mellitus (T2DM) is a recognised risk factor for several cardiovascular (CV) conditions including heart failure (HF). Findings that reflect CV risk associated with T2DM medications have led to regulatory requirement of conducting CV outcome trials (CVOTs) for new antidiabetes drugs. O...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/dd839f2ab3bf4e1e9d6388f31d4cd802 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|